- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.3: 2 residues within 4Å:- Chain A: N.331, Q.580
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.4: 5 residues within 4Å:- Chain A: F.342, N.343, V.367, S.371, S.373
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.12: 2 residues within 4Å:- Chain B: N.331, Q.580
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 5 residues within 4Å:- Chain B: F.342, N.343, V.367, S.371, S.373
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.21: 2 residues within 4Å:- Chain C: N.331, Q.580
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.22: 5 residues within 4Å:- Chain C: F.342, N.343, V.367, S.371, S.373
No protein-ligand interaction detected (PLIP)- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.28: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain A: Q.115, E.132, N.165, T.167
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: G.232, N.234
- Chain B: H.519
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain A: N.616, T.618
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain A: C.1082, N.1125, C.1126, D.1127, N.1134
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain B: Q.115, E.132, N.165, T.167
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain B: G.232, N.234
- Chain C: H.519
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: N.616, T.618
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain B: C.1082, N.1125, C.1126, D.1127, N.1134
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain C: Q.115, E.132, N.165, T.167
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain A: H.519
- Chain C: G.232, N.234
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: N.616, T.618
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.45: 5 residues within 4Å:- Chain C: C.1082, N.1125, C.1126, D.1127, N.1134
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Miersch, S. et al., Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations. J.Mol.Biol. (2021)
- Release Date
- 2021-02-10
- Peptides
- Spike glycoprotein: ABC
Fab 15033-7 light chain: DFH
Fab 15033-7 heavy chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
LF
MH
NE
HG
II
J
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Miersch, S. et al., Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations. J.Mol.Biol. (2021)
- Release Date
- 2021-02-10
- Peptides
- Spike glycoprotein: ABC
Fab 15033-7 light chain: DFH
Fab 15033-7 heavy chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
LF
MH
NE
HG
II
J